The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis

References

• Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology (Baltimore, Md.). 2018;67(1):328-357.
   Google Scholar
• Wong VW, Wong GL, Yip GW, et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut. 2011;60(12):1721.
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology (Baltimore, Md.). 2016;64(1):73–84.
   PubMed Web of Science ®Google Scholar
• Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140(1):124–131.
   PubMed Web of Science ®Google Scholar
• Fan JG, Kim SU, Wong VW. New trends on obesity and nafld in Asia. J Hepatol. 2017;67:862–873.
   PubMed Web of Science ®Google Scholar
• Naderian M, Kolahdoozan S, Sharifi AS, et al. Assessment of lean patients with non-alcoholic fatty liver disease in a middle income country; prevalence and its association with metabolic disorders: a cross-sectional study. Arch Iran Med. 2017;20(4):211–217.
   PubMed Web of Science ®Google Scholar
• Succurro E, Marini MA, Frontoni S, et al. Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity. 2008;16(8):1881–1886.
   PubMed Web of Science ®Google Scholar
• Stevens GA, Singh GM, Lu Y, et al. National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr. 2012;10:22.
   PubMed Web of Science ®Google Scholar
• Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. The Lancet. 2008;371(9612):569–578.
   PubMed Web of Science ®Google Scholar
• Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579–591.
   PubMed Web of Science ®Google Scholar
• Li L, Liu DW, Yan HY, et al. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev. 2016;17(6):510–519.
   PubMed Web of Science ®Google Scholar
• Alam S, Gupta UD, Alam M, et al. Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh. Indian J Gastroenterol. 2014;33(5):452–457.
   PubMedGoogle Scholar
• Kwon YM, Oh SW, Hwang SS, et al. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. Am J Gastroenterol. 2012;107(12):1852–1858.
   PubMed Web of Science ®Google Scholar
• Leung JC, Loong TC, Wei JL, et al. Histological severity and clinical outcomes of nonalcoholic fatty liver disease in non‐obese patients. Hepatology (Baltimore, Md.). 2017;65(1):54.
   PubMed Web of Science ®Google Scholar
• Vos B, Moreno C, Nagy N, et al. Lean non-alcoholic fatty liver disease (lean-NAFLD): a major cause of cryptogenic liver disease. Acta Gastroenterol Belg. 2011;74(3):389–394.
   PubMed Web of Science ®Google Scholar
• Sookoian S, Pirola CJ. Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. Aliment Pharmacol Ther. 2017;46(2):85–95.
   PubMed Web of Science ®Google Scholar
• Sookoian S, Pirola CJ. Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2018;47(1):16-25.
   Web of Science ®Google Scholar
• Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver Fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(2):389–397.e310.
   PubMed Web of Science ®Google Scholar
• Sookoian S, Pirola CJ. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.). 2011;53(6):1883–1894.
   PubMed Web of Science ®Google Scholar
• WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet. 2004;363(9403):157–163.
   PubMed Web of Science ®Google Scholar
• Kumar R, Rastogi A, Sharma MK, et al. Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: do they differ from obese or overweight non-alcoholic fatty liver disease? Indian J Endocrinol Metab. 2013;17(4):665–671.
   PubMedGoogle Scholar
• Chen CH, Huang MH, Yang JC, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol. 2006;40(8):745–752.
   PubMed Web of Science ®Google Scholar
• Kim JY, Lee C, Oh M, et al. Relationship between non-alcoholic fatty liver disease, metabolic syndrome and insulin resistance in Korean adults: A cross-sectional study. Clin Chim Acta. 2016;458:12–17.
   PubMed Web of Science ®Google Scholar
• Lankarani KB, Ghaffarpasand F, Mahmoodi M, et al. Non alcoholic fatty liver disease in southern Iran: a population based study. Hepat Mon. 2013;13(5):e9248.
   PubMed Web of Science ®Google Scholar
• Nishioji K, Mochizuki N, Kobayashi M, et al. The Impact of PNPLA3 rs738409 genetic polymorphism and weight gain≥10 kg after age 20 on non-alcoholic fatty liver disease in non-obese japanese individuals. PloS One. 2015;10(10):e0140427.
   PubMed Web of Science ®Google Scholar
• Nishioji K, Sumida Y, Kamaguchi M, et al. Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011-2012. J Gastroenterol. 2015;50(1):95–108.
   PubMed Web of Science ®Google Scholar
• Wang Z, Xu M, Hu Z, et al. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index. Menopause (New York, N.Y.). 2015;22(6):667–673.
   PubMed Web of Science ®Google Scholar
• Wei JL, Leung JC, Loong TC, et al. Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: a population study using proton-magnetic resonance spectroscopy. Am J Gastroenterol. 2015;110(9):1306–1314.
   PubMed Web of Science ®Google Scholar
• Honda Y, Yoneda M, Kessoku T, et al. Characteristics of non-obese non-alcoholic fatty liver disease: effect of genetic and environmental factors. Hep Res. 2016;46(10):1011–1018.
   PubMed Web of Science ®Google Scholar
• Stepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Gut. 2010;59(10):1410–1415.
   PubMed Web of Science ®Google Scholar
• Otgonsuren M, Stepanova M, Gerber L, et al. Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver disease. Dig Dis Sci. 2013;58(4):1132–1140.
   PubMed Web of Science ®Google Scholar
• Cruz ACD, Bugianesi E, George J, et al. Characteristics and long-term prognosis of lean patients with nonalcoholic fatty liver disease. Gastroenterology. 2014;146(5):S–909.
   Web of Science ®Google Scholar
• Kawamura Y, Arase Y, Ikeda K, et al. Large-scale long-term follow-up study of Japanese patients with non-alcoholic fatty liver disease for the onset of hepatocellular carcinoma. Am J Gastroenterol. 2012;107(2):253–261.
   PubMed Web of Science ®Google Scholar
• Huh JH, Kim KJ, Kim SU, et al. Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status. Metabolism. 2017;66:23–31.
   PubMed Web of Science ®Google Scholar
• Newgard DMC. Obesity-related derangements in metabolic regulation. Annu Rev Biochem. 2006;75(1):367.
   PubMedGoogle Scholar
• Kebede MA, Attie AD. Insights into obesity and diabetes at the intersection of mouse and human genetics. Trends Endocrinol Metab. 2014;25(10):493–501.
   PubMed Web of Science ®Google Scholar
• Milic S, Lulic D, Stimac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol. 2014;20(28):9330–9337.
   PubMed Web of Science ®Google Scholar
• du Plessis J, van Pelt J, Korf H, et al. Association of adipose tissue inflammation with histologic severity of nonalcoholic fatty liver disease. Gastroenterology. 2015;149(3):635–648.e614.
   PubMed Web of Science ®Google Scholar
• Cusi K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology. 2012;142(4): 711–725 e716.
   PubMed Web of Science ®Google Scholar
• Peverill W, Powell LW, Skoien R. Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. Int J Mol Sci. 2014;15(5):8591–8638.
   PubMed Web of Science ®Google Scholar
• Srikanthan K, Feyh A, Visweshwar H, et al. Systematic review of metabolic syndrome biomarkers: a panel for early detection, management, and risk stratification in the west virginian population. Int J Med Sci. 2016;13(1):25–38.
   PubMed Web of Science ®Google Scholar
• Buzzetti E, Pinzani M, Ea T. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism-Clinical Exp. 2016;65(8):1038.
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology (Baltimore, Md.). 2010;52(5):1836–1846.
   PubMed Web of Science ®Google Scholar
• Kim HK, Park JY, Lee KU, et al. Effect of body weight and lifestyle changes on long-term course of nonalcoholic fatty liver disease in Koreans. Am J Med Sci. 2009;337(2):98–102.
   PubMed Web of Science ®Google Scholar
• Klein S, Mittendorfer B, Eagon JC, et al. Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology. 2006;130(6):1564–1572.
   PubMed Web of Science ®Google Scholar
• Simmonds MC, Higgins JP, Stewart LA, et al. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials. 2005;2(3):209.
   PubMed Web of Science ®Google Scholar
• Margarit A, Deutsch M, Manolakopoulos S, et al. The severity of histologic liver lesions is independent of body mass index in patients with nonalcoholic fatty liver disease. J Clin Gastroenterol. 2013;47(3):280–286.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388–1402.
   PubMed Web of Science ®Google Scholar